Edition:
India

Shandong Weigao Group Medical Polymer Co Ltd (1066.HK)

1066.HK on Hong Kong Stock

5.34HKD
11 Dec 2017
Change (% chg)

HK$0.07 (+1.33%)
Prev Close
HK$5.27
Open
HK$5.27
Day's High
HK$5.38
Day's Low
HK$5.24
Volume
1,368,000
Avg. Vol
3,107,770
52-wk High
HK$6.53
52-wk Low
HK$4.50

Chart for

About

Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is... (more)

Overall

Beta: 0.67
Market Cap(Mil.): HK$26,500.87
Shares Outstanding(Mil.): 4,522.33
Dividend: 0.05
Yield (%): 1.80

Financials

Chinese firms among bidders for Australia's I-MED, valued at over $765 million - sources

HONG KONG/SYDNEY Two Chinese healthcare firms are among investors seeking to buy Australia's I-MED Radiology Network in a deal that could value the X-ray provider at more than A$1 billion ($765 million), people with knowledge of the matter said.

01 Nov 2017

UPDATE 1-Chinese firms among bidders for Australia's I-MED, valued at over $765 mln -sources

* Tonghua Golden-Horse, Golden Meditech among bidders -sources

01 Nov 2017

Chinese medical devices maker to buy US-based Argon for $850 mln

HONG KONG, Sept 24 China's Shandong Weigao Group Medical Polymer Co Ltd has agreed to acquire US-based and unlisted Argon Medical Devices Holdings Inc for $850 million, as part of its overseas expansion drive.

24 Sep 2017

BRIEF-Shandong Weigao Group Medical Polymer submits takeover bid for US-based company

Sept 1 Shandong Weigao Group Medical Polymer Co Ltd

01 Sep 2017

BRIEF-Shandong Weigao Group Medical Polymer Co entered into deposit services agreement

Aug 23 Shandong Weigao Group Medical Polymer Co Ltd :

23 Aug 2017

BRIEF-Shandong Weigao Group Medical Polymer HY turnover RMB3.57 bln, up 11.9%

Aug 23 Shandong Weigao Group Medical Polymer Co Ltd-

23 Aug 2017

Earnings vs. Estimates